Cargando…
An inhibitor of ubiquitin conjugation and aggresome formation
Proteasome inhibitors have revolutionized the treatment of multiple myeloma, and validated the therapeutic potential of the ubiquitin proteasome system (UPS). It is believed that in part, proteasome inhibitors elicit their therapeutic effect by inhibiting the degradation of misfolded proteins, which...
Autores principales: | An, Heeseon, Statsyuk, Alexander V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500945/ https://www.ncbi.nlm.nih.gov/pubmed/28717502 http://dx.doi.org/10.1039/c5sc01351h |
Ejemplares similares
-
Protein ubiquitination and formation of polyubiquitin chains without ATP, E1 and E2 enzymes
por: Park, Sungjin, et al.
Publicado: (2015) -
USP10 Is a Driver of Ubiquitinated Protein Aggregation and Aggresome Formation to Inhibit Apoptosis
por: Takahashi, Masahiko, et al.
Publicado: (2018) -
Hook2 contributes to aggresome formation
por: Szebenyi, Györgyi, et al.
Publicado: (2007) -
Autophagic sequestration of SQSTM1 disrupts the aggresome formation of ubiquitinated proteins during proteasome inhibition
por: Zhang, Chenliang, et al.
Publicado: (2022) -
Inhibition of SQSTM1 S403 phosphorylation facilitates the aggresome formation of ubiquitinated proteins during proteasome dysfunction
por: Zhang, Chenliang, et al.
Publicado: (2023)